Koyfin Home > Directory > Health Care > Acceleron Pharma > Cash Flow from Operations

Acceleron Pharma Cash Flow from Operations Chart (XLRN)

Acceleron Pharma annual/quarterly Cash Flow from Operations from 2012 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Acceleron Pharma Cash Flow from Operations for the quarter ending June 06, 2020 was $-43m a 13.56% decrease of -6m year over year
  • Acceleron Pharma Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-143m a 25.31% decrease of -36m year over year
  • Acceleron Pharma Annual Cash Flow from Operations for 2019 was $-94m a -0.96% increase of 1m from 2018
  • Acceleron Pharma Annual Cash Flow from Operations for 2018 was $-95m a 19.18% decrease of -18m from 2017
  • Acceleron Pharma Annual Cash Flow from Operations for 2017 was $-77m a 41.80% decrease of -32m from 2016
Other Cash Flow Metrics:
  • Acceleron Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-41m a 62.43% decrease of -26m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Cash Flow from Operations Data

06/2020$-43m
03/2020$-47m
12/2019$-16m
09/2019$-37m
06/2019$-14m
03/2019$-26m
12/2018$-29m
09/2018$-20m
06/2018$-22m
03/2018$-23m

Annual XLRN Cash Flow from Operations Data

2019$-94m
2018$-95m
2017$-77m
2016$-45m
2015$-44m
2014$-53m
2013$-20m
2012$-39m
2011$9m